STOCK TITAN

Y-mAbs Therapeutics, Inc. (YMAB) Free Cash Flow by Year

YMAB

Y-mAbs Therapeutics, Inc. does not report free cash flow for fiscal year 2024, so the figure is not reported on this page. The table below carries 8 fiscal years, from 2017 to 2024, and the quarters Y-mAbs Therapeutics, Inc. has filed alongside them.

FY2024 annual
Free Cash Flow N/A
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

YMAB Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
Free Cash FlowN/AN/AN/A-$103.2M-12.9%-$91.4M-21.1%-$75.5M-82.0%-$41.5MN/A

YMAB Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-Q
Free Cash Flow$1.7M-$7.0MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Y-mAbs Therapeutics, Inc. financials

Frequently Asked Questions

What was Y-mAbs Therapeutics, Inc.'s free cash flow in fiscal year 2024?

Y-mAbs Therapeutics, Inc. does not report free cash flow for fiscal year 2024, so the figure is not reported on this page.

What was Y-mAbs Therapeutics, Inc.'s free cash flow in the most recent quarter?

Y-mAbs Therapeutics, Inc. (YMAB) reported $1.7M in free cash flow in Q2 2025.

What does free cash flow mean on a financial statement?

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Y-mAbs Therapeutics, Inc. (YMAB) reported on that line in every period on record.